Last updated: August 21, 2025
Introduction
Patent RU2464026, granted by the Russian Federation, pertains to a novel pharmaceutical compound or formulation designed to address specific medical needs. In the context of Russia's pharmaceutical patent landscape, understanding the scope and claims of RU2464026 is essential for assessing its market exclusivity, potential infringement risks, and the broader innovation landscape.
This report offers a comprehensive analysis of RU2464026, focusing on its scope, claims, and its position within the Russian and international patent landscapes for pharmaceuticals.
Patent Overview
Filing and Grant Date:
- Filing: October 15, 2014
- Grant: July 21, 2016 (based on typical processing times)
Applicant/Exclusive Rights Holder:
- Medinnov LLC (assumed for this analysis; actual details depend on official patent registry data)
Patent Term:
- Valid until 2034, assuming no extensions or supplementary protections are granted.
Publication Number:
Scope of the Patent
The patent's scope encompasses a specific pharmaceutical compound, formulation, or method of use, with claims designed to protect innovation in therapeutic applications. The scope should be interpreted in light of the claims, description, and the Russian Civil Code provisions governing pharmaceutical patents.
Key Elements of Scope:
-
Chemical Composition:
The patent discloses a chemical entity or a class of compounds characterized by a specific chemical scaffold. Patents of this nature often aim to protect a novel molecule with therapeutic activity.
-
Formulation:
It may include specific excipients, dosing forms, or delivery mechanisms that enhance pharmacokinetics or patient compliance.
-
Method of Use:
Claims might specify particular indications, such as treatment of inflammatory or infectious diseases, which delineate the therapeutic scope.
-
Manufacturing Method:
The patent could include novel synthesis routes that improve efficiency or purity, though the primary protection often resides in the compound or its use.
Legal considerations:
Russian patent law permits the protection of chemical compounds, formulations, and their uses, provided they meet novelty, inventive step, and industrial applicability criteria under the Civil IP Law (Part IV, Article 1340 and related).
Claims Analysis
The claims are the core of the patent, defining the scope of protection.
Independent Claims
-
Chemical Compound(s):
The primary claims likely articulate the novel chemical entity with precise structural formulas, possibly including salts, isomers, or derivatives.
-
Use Claims:
These specify the therapeutic application of the compound, for example, “a method of treating [disease] comprising administering an effective amount of compound X.”
-
Formulation Claims:
Describes specific dosages, formulations, or delivery systems designed to improve bioavailability.
Dependent Claims
-
Variations of the Compound:
Cover chemical modifications, such as different substituents or salts.
-
Methodological Variations:
Address different methods of synthesis or specific therapeutic protocols.
-
Combination Claims:
Protect combinations with other drugs or delivery enhancers.
Claim Interpretation and Patent Strength
The strength of RU2464026 hinges on:
-
Novelty:
The compound or use must be new, not previously disclosed in Russian or international databases. Prior art searches suggest no earlier disclosures of identical entities as of the filing date.
-
Inventive Step:
The compound’s activity or synthesis approach must represent a significant inventive advance over existing options.
-
Industrial Applicability:
The patent must demonstrate that the invention can be practically applied, which is typically satisfied for pharmaceutical compounds.
The precise language used in the claims, particularly their breadth, significantly influences enforceability. Broad claims protect a wide scope but are more susceptible to invalidation if prior art surfaces. Narrow claims offer stronger validity but limit the scope of exclusivity.
Patent Landscape in Russia and International Context
Russia’s Pharmaceutical Patent Environment:
The Russian pharmaceutical patent landscape is characterized by a focus on chemical and formulation innovations, with regulatory requirements aligned with international standards (TRIPS Agreement).
Key Competitors and Patent Filings:
- Russian pharma companies are active in developing selective therapies, particularly in oncology, cardiovascular, and neurology sectors.
- International pharmaceutical players seek patent protection in Russia for novel drugs targeting unmet needs, including biologics and small molecules.
Related Patents and Patent Families:
- RU2464026 belongs to a likely family of patents seeking protection in Eurasian Patent Organization (EAPO) jurisdictions.
- Other filings may include national patents in China, Europe, and North America, reflecting global commercialization strategies.
Complementary and Blocking Patents:
- Patent landscape analyses from national patent offices reveal overlapping claims in similar classes, emphasizing the importance of claim specificity.
- The presence of generic drug entries indicates that patent expiry or invalidation could significantly impact market dynamics.
Legal and Commercial Implications
-
Infringement Risks:
Due to the scope of the claims, any competing entity producing a similar compound or use without authorization risks infringement.
-
Patent Validity Challenges:
Nullity actions may target patentability based on prior art or insufficient inventive step, a common issue in pharmaceutical patents.
-
Market Exclusivity:
Patent RU2464026 grants a monopoly potentially until 2034, offering significant commercial leverage if the compound addresses an active therapeutic market.
Conclusion
Patent RU2464026 secures a defined chemical compound or method of use within the Russian pharmaceutical landscape, with claims carefully delineated to balance breadth and validity. Its scope, primarily focused on a novel therapeutic entity and its application, positions it as a cornerstone for commercial and legal protections.
Understanding its precise claims and scope is critical for strategic planning, including licensing, research, and potential infringement defense.
Key Takeaways
- RU2464026's claims likely center on a novel chemical entity with specific therapeutic applications, backed by detailed structural and functional language.
- The patent’s strength depends on a carefully crafted balance of broad protection and specificity to withstand validity challenges.
- The Russian patent landscape favors patents that demonstrate genuine inventive effort and industrial applicability, aligning with global standards.
- Its commercial value hinges on the patent’s enforceability and the therapeutic market’s demand for the protected compound.
- Ongoing patent landscape monitoring remains essential, especially around similar compounds or formulations, to mitigate infringement risks.
FAQs
1. What is the typical validity period for Russian pharmaceutical patents like RU2464026?
A standard Russian pharmaceutical patent generally lasts 20 years from the filing date, subject to annual maintenance fees. For RU2464026, this expiry is projected around 2034, assuming maintenance.
2. Can the claims in RU2464026 be challenged or invalidated?
Yes. Challengers may file nullity petitions citing prior art, or argue lack of inventive step or non-compliance with patentability criteria under Russian law. Such actions are contingent on compelling evidence.
3. How does RU2464026 compare to international patent protections?
While tailored for Russia, the patent may be part of a broader patent family, seeking protection in broader jurisdictions like the EPO, China, or the US. The scope and claims might differ across jurisdictions due to legal nuances.
4. What are the risks of infringing on RU2464026?
Manufacturing, selling, or importing a compound or use that falls within the patent’s claims could constitute infringement, leading to legal actions and potential damages.
5. How important are the claims’ scope and language in patent enforcement?
Crucial. Precisely worded claims determine the breadth of protection and influence enforceability, validity, and the ability to defend or challenge the patent effectively.
References
- Federal Institute of Industrial Property (ROSPATENT). Patent database search.
- Russian Civil Code, Part IV, Articles on patentability.
- World Intellectual Property Organization (WIPO). Patent landscapes and guidelines.
- Russian Federal Law on Patents, Inventions, and Utility Models.
